多囊卵巢综合征的现行诊断指南。
Current Guidelines for Diagnosing PCOS.
作者信息
Christ Jacob P, Cedars Marcelle I
机构信息
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA 94143, USA.
出版信息
Diagnostics (Basel). 2023 Mar 15;13(6):1113. doi: 10.3390/diagnostics13061113.
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of reproductive-aged women. Much of the confusion surrounding PCOS diagnosis stems from the broad heterogeneity of symptomology experienced by women with PCOS. The diverse features of the syndrome have led to a number of diagnostic criteria over the years. This manuscript describes each of the current composite criteria and individually breaks down each component. The importance of accurate diagnosis for both clinical care and research is emphasized.
摘要
多囊卵巢综合征（PCOS）是育龄女性最常见的内分泌疾病。围绕PCOS诊断的许多困惑源于患有PCOS的女性症状学的广泛异质性。多年来，该综合征的多样特征导致了多种诊断标准。本文描述了当前的每一种综合标准，并分别剖析了每个组成部分。强调了准确诊断对临床护理和研究的重要性。
相似文献
1
Current Guidelines for Diagnosing PCOS.
Diagnostics (Basel). 2023 Mar 15;13(6):1113. doi: 10.3390/diagnostics13061113.
2
The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Hum Reprod. 2014 Apr;29(4):791-801. doi: 10.1093/humrep/det469. Epub 2014 Jan 16.
3
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
Hum Reprod. 2016 Dec;31(12):2841-2855. doi: 10.1093/humrep/dew218. Epub 2016 Sep 22.
4
Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
J Clin Endocrinol Metab. 2006 Mar;91(3):781-5. doi: 10.1210/jc.2005-2153. Epub 2006 Jan 17.
5
Prevalence, clinical characteristics, and reproductive outcomes of polycystic ovary syndrome in older women referred for tertiary fertility care.
Arch Gynecol Obstet. 2018 Apr;297(4):1037-1042. doi: 10.1007/s00404-017-4642-z. Epub 2017 Dec 30.
6
High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
Horm Res Paediatr. 2017;87(5):333-341. doi: 10.1159/000471805. Epub 2017 Apr 24.
7
[Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
Zhonghua Fu Chan Ke Za Zhi. 2011 Mar;46(3):177-80.
8
Clinicians' perspectives on diagnosing polycystic ovary syndrome in Australia: a qualitative study.
Hum Reprod. 2020 Mar 27;35(3):660-668. doi: 10.1093/humrep/deaa005.
9
Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
Hum Reprod. 2021 May 17;36(6):1611-1620. doi: 10.1093/humrep/deab069.
10
Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria.
J Clin Endocrinol Metab. 2006 Mar;91(3):786-9. doi: 10.1210/jc.2005-2501. Epub 2006 Jan 17.
引用本文的文献
1
Polycystic Ovary Syndrome and the Effects of a Ketogenic Diet: A Scoping Review.
Nutrients. 2025 Sep 7;17(17):2893. doi: 10.3390/nu17172893.
2
Molecular Insights into Elevated Autoantibodies in Polycystic Ovary Syndrome: Mechanisms and Clinical Implications.
Int J Mol Sci. 2025 Aug 23;26(17):8192. doi: 10.3390/ijms26178192.
3
Temporal Trends and Machine Learning-Based Risk Prediction of Female Infertility: A Cross-Cohort Analysis Using NHANES Data (2015-2023).
Diagnostics (Basel). 2025 Sep 5;15(17):2250. doi: 10.3390/diagnostics15172250.
4
Hypertension and Polycystic Ovary Syndrome Among Women in a Nationwide Electronic Health Records Dataset in the United States.
Matern Child Health J. 2025 Sep 1. doi: 10.1007/s10995-025-04155-x.
5
Knowledge, Attitude, and Practice of Polycystic Ovarian Syndrome Diagnosis among Health Care Providers in Addis Ababa, Ethiopia.
BMC Womens Health. 2025 Aug 29;25(1):414. doi: 10.1186/s12905-025-03948-0.
6
Obesity as a Part of Polycysric Ovary Syndrome (PCOS)-A Review of Pathophysiology and Comprehensive Therapeutic Strategies.
J Clin Med. 2025 Aug 9;14(16):5642. doi: 10.3390/jcm14165642.
7
Multifactorial Refractory Acne in Women: Insights from a Case Series Involving Hormonal-, Metabolic-, and Corticosteroid-Related Triggers.
Life (Basel). 2025 Jul 28;15(8):1196. doi: 10.3390/life15081196.
8
Visceral Adiposity Index in Relation to Rotterdam Phenotypes of Polycystic Ovary Syndrome.
Biomedicines. 2025 Aug 16;13(8):1997. doi: 10.3390/biomedicines13081997.
9
FIB-4 Score as a Predictor of Eligibility for Elastography Exam in Patients with Polycystic Ovary Syndrome.
Biomedicines. 2025 Aug 1;13(8):1878. doi: 10.3390/biomedicines13081878.
10
Comparative advantage and efficacy of natural products for polycystic ovary syndrome.
J Ovarian Res. 2025 Aug 9;18(1):178. doi: 10.1186/s13048-025-01756-6.
本文引用的文献
1
Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome.
J Clin Endocrinol Metab. 2022 Aug 18;107(9):e3714-e3722. doi: 10.1210/clinem/dgac370.
2
Changes in individual polycystic ovary syndrome phenotypical characteristics over time: a long-term follow-up study.
Fertil Steril. 2022 May;117(5):1059-1066. doi: 10.1016/j.fertnstert.2022.01.014. Epub 2022 Feb 24.
3
Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences.
J Clin Endocrinol Metab. 2022 Jan 18;107(2):575-585. doi: 10.1210/clinem/dgab613.
4
Age-group-specific reference intervals for anti-Müllerian hormone and its diagnostic performance for polycystic ovary syndrome in a Korean population.
J Clin Lab Anal. 2021 Jul;35(7):e23861. doi: 10.1002/jcla.23861. Epub 2021 Jun 7.
5
The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review.
J Hum Reprod Sci. 2020 Oct-Dec;13(4):261-271. doi: 10.4103/jhrs.JHRS_95_18. Epub 2020 Dec 28.
6
Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis.
Gynecol Endocrinol. 2021 May;37(5):392-405. doi: 10.1080/09513590.2020.1859474. Epub 2020 Dec 23.
7
Adolescent polycystic ovary syndrome according to the international evidence-based guideline.
BMC Med. 2020 Mar 24;18(1):72. doi: 10.1186/s12916-020-01516-x.
8
Age-specific reference ranges of serum anti-müllerian hormone in healthy women and its application in diagnosis of polycystic ovary syndrome: a population study.
BJOG. 2020 May;127(6):720-728. doi: 10.1111/1471-0528.16147. Epub 2020 Feb 25.
9
Female Androgenetic Alopecia: An Update on Diagnosis and Management.
Am J Clin Dermatol. 2020 Feb;21(1):69-84. doi: 10.1007/s40257-019-00479-x.
10
Real-world menstrual cycle characteristics of more than 600,000 menstrual cycles.
NPJ Digit Med. 2019 Aug 27;2:83. doi: 10.1038/s41746-019-0152-7. eCollection 2019.
Zotero 插件